Ketamine: reclassification alone will not reduce harms
Key Points
Reclassifying ketamine alone is unlikely to mitigate harm effectively, as more comprehensive public health strategies are needed.
Public health actions must accompany legal changes to significantly impact harm reduction related to ketamine use.
The commentary argues for a holistic approach to drug policy that integrates legal, educational, and health interventions.
Failure to implement parallel public health measures may render reclassification a mere symbolic move rather than a meaningful solution.
Abstract
Without parallel public health action, reclassifying ketamine risks being a symbolic gesture rather than a strategy to reduce harm, write Adam Winstock, David Nutt, and Caroline Copeland
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Ketamine: reclassification alone will not reduce harms | Synapse